Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) Net Margin: 2021-2025

Historic Net Margin for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -382.69%.

  • ProQR Therapeutics N.V's Net Margin fell 16189.00% to -382.69% in Q3 2025 from the same period last year, while for Sep 2025 it was -283.23%, marking a year-over-year decrease of 14985.00%. This contributed to the annual value of -146.86% for FY2024, which is 28481.00% up from last year.
  • ProQR Therapeutics N.V's Net Margin amounted to -382.69% in Q3 2025, which was down 13.58% from -336.94% recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Net Margin ranged from a high of -42.70% in Q2 2024 and a low of -8,941.13% during Q1 2021.
  • In the last 3 years, ProQR Therapeutics N.V's Net Margin had a median value of -231.25% in 2025 and averaged -386.57%.
  • Over the last 5 years, ProQR Therapeutics N.V's Net Margin had its largest YoY gain of 769,255bps in 2022, and its largest YoY loss of 113,905bps in 2022.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Net Margin stood at -7,623.85% in 2021, then spiked by 577,704bps to -1,846.81% in 2022, then spiked by 169,650bps to -150.30% in 2023, then tumbled by 6,339bps to -213.70% in 2024, then tumbled by 16,189bps to -382.69% in 2025.
  • Its Net Margin was -382.69% in Q3 2025, compared to -336.94% in Q2 2025 and -231.25% in Q1 2025.